Straumann (OTCMKTS:SAUHY) is a Switzerland‐based company specializing in tooth replacement and restorative dental solutions. Founded in 1954 as part of Basel University’s Institute for Reconstructive Dentistry, Straumann pioneered the development of titanium dental implants and has since grown into one of the world’s leading implantology manufacturers. The company’s products and services span the full patient journey, from initial diagnosis through surgical placement to prosthetic restoration, supporting clinicians with precision‐engineered implants, abutments and ceramic prostheses.
Core offerings include a broad portfolio of dental implants—ranging from bone‐level and tissue‐level implants to immediate‐loading solutions—alongside complementary surgical instruments and digital planning software. Straumann has expanded into digital dentistry with intraoral scanners, CAD/CAM prosthetic workflows and 3D‐printed surgical guides. Its orthodontic arm, ClearCorrect, provides clear aligner systems, while its Neodent and Anthogyr brands deliver cost‐effective implant options for emerging markets. This integrated ecosystem enables dental professionals to streamline treatment planning, improve clinical outcomes and enhance patient satisfaction.
The company maintains a presence in over 100 countries, with regional headquarters in Europe, North America, Latin America and Asia Pacific. Straumann’s global network includes a mix of direct sales operations and distributor partnerships, enabling tailored support for private practices, dental chains and academic institutions. In Brazil, the Neodent business unit has become a significant player in the implant market, while ClearCorrect has gained market share in the United States. Straumann’s digital solutions are now deployed in key markets across Europe and Asia, reflecting its commitment to innovation in prosthetic and orthodontic workflows.
Leadership at Straumann underscores its focus on research, quality and long‐term growth. Under the direction of CEO Guillaume Daniellot and Chairman Joerg Reinhardt, the company invests heavily in R&D partnerships, clinical studies and professional education programs. With manufacturing facilities in Switzerland, Germany and the United States, and a comprehensive service infrastructure, Straumann continues to advance dental care through a combination of precision engineering, digital transformation and evidence‐based clinical support.
AI Generated. May Contain Errors.
Free SAUHY Stock Alerts